Pump Supplies denied as not medically necessary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pump supplies are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denies Pump Supplies on Medical-Necessity Grounds

Blue Cross Blue Shield's medical-necessity denials for insulin pump supplies typically reflect a determination that the clinical documentation does not demonstrate that pump therapy — rather than multiple daily injections (MDI) — is medically required for the patient's specific situation. BCBS's coverage policies for insulin pump therapy commonly require documented evidence of inadequate glycemic control on optimized injection therapy, or specific clinical circumstances that make pump therapy the appropriate standard of care. Denials often result from incomplete documentation rather than a genuine clinical disagreement.

These denials are highly appealable, particularly when the treating endocrinologist or diabetes care provider has directly evaluated the patient and can document the clinical basis for pump therapy.

## Your Federal Appeal Rights

• Internal appeal: ACA §2719 and ERISA §503 guarantee a full clinical review. BCBS must identify the specific medical-necessity criteria it applied and explain exactly what documentation was missing or insufficient.
• External review: Independent external review by a clinician with relevant expertise is available after internal exhaustion, typically within approximately four months of final denial.
• Expedited track: If the denial creates an immediate risk — for example, if the patient is already on pump therapy and supply denial would force an abrupt return to injections — request expedited review and document the safety risk explicitly.

## Documentation to Gather

1. Diagnosis confirmation — chart documentation of the diabetes diagnosis, type, duration, and current treatment regimen. 2. Glycemic history — records of HbA1c values, fasting and post-prandial glucose logs, and frequency of hypoglycemic events over the relevant period. Do not submit raw numbers without clinical context — your physician should interpret them. 3. Prior therapy documentation — records showing what insulin regimen was used previously, for how long, and what the clinical outcomes were. If MDI was trialed and found inadequate, document this specifically with dates. 4. Prescriber medical-necessity letter — a detailed letter from your endocrinologist or prescribing physician explaining, criterion by criterion, why pump therapy is medically necessary for you. This letter should address BCBS's specific criteria. 5. BCBS coverage criteria — obtain BCBS's clinical policy for insulin pump coverage (available on the BCBS member portal or by request) and ensure each criterion is explicitly addressed.

## Criteria-Mapping Structure

| BCBS Medical-Necessity Criterion | Your Chart Evidence | |---|---| | [Paste each criterion from BCBS's policy] | [Quote chart note, date, and clinician name] |

## Next Step

The most common reason these appeals fail is a physician letter that addresses general clinical principles rather than BCBS's specific criteria. Request the exact policy language first, then build the documentation response around each requirement.